ODI in overseas fund by Indian company

Yes, an Indian company can make an overseas investment in a foreign fund (such as a pharma fund), but it is important to distinguish between Overseas Direct Investment (ODI) and Overseas Portfolio Investment (OPI), as the regulations differ significantly.

1. Classification of the Investment

• Overseas Portfolio Investment (OPI): If the Indian company is investing in units of an overseas investment fund that is regulated by the financial sector regulator of the host jurisdiction, this typically qualifies as OPI. As of recent updates to the Foreign Exchange Management (Overseas Investment) Directions, "Regulated Funds" (including those structured as limited partnerships or variable capital companies managed by regulated fund managers) are included under OPI.

• Overseas Direct Investment (ODI): If the investment involves "control" or meets specific thresholds (such as 10% or more of the paid-up equity capital of a listed foreign entity), it may be classified as ODI.

2. General Regulatory Conditions

• Bonafide Business Activity: The foreign entity or fund must be engaged in a "bonafide business activity," which means the activity must be permissible under the laws of both India and the host jurisdiction.

• Restricted Sectors: Indian entities are strictly prohibited from making investments in foreign entities engaged in certain activities, such as:

  • Real estate (trading or buying/selling).

  • Gambling (casinos, betting).

• Financial Commitment Limits: Under the ODI framework, the total financial commitment of an Indian entity in all foreign entities generally should not exceed 400% of its net worth (as per the last audited balance sheet) or USD 1 billion, whichever is lower. Investments exceeding these limits generally require the Approval Route (prior RBI approval).

3. Procedural Requirements

• Authorized Dealer (AD) Bank: All outward remittances and reporting must be routed through an AD Bank. You must submit the necessary documentation (Form ODI, board resolutions, etc.) to your AD Bank.

• Unique Identification Number (UIN): For ODI, a UIN must be generated through the AD Bank for the foreign entity. Subsequent transactions are reported against this UIN.

• Reporting: You are required to file an Annual Performance Report (APR) for your overseas investments by December 31 each year to remain in compliance.

Important Considerations

• Regulatory Status: Always verify that the pharma fund you intend to invest in is indeed "regulated" by the financial sector regulator in its home country. The RBI's liberalized framework for OPI specifically hinges on this regulatory oversight in the host jurisdiction.

• Avoidance of "Round-Tripping": Ensure the investment structure does not violate rules against multi-layered subsidiaries or "round-tripping" (where the foreign entity invests back into India), as this can trigger complex compliance requirements.

Summary

An Indian company can invest in an overseas pharma fund. If the investment is passive and the fund is regulated in its host country, it is typically treated as Overseas Portfolio Investment (OPI). If the investment involves "control" or significant equity stakes, it may fall under Overseas Direct Investment (ODI), which is subject to a financial commitment cap of 400% of net worth. You must route all investments through an Authorized Dealer (AD) Bank and ensure the fund is not engaged in prohibited activities like gambling or real estate. Always consult with your company's legal or tax counsel to review the specific structure of the fund to ensure full compliance with the current FEMA (Overseas Investment) Rules.